Risk factors

ProMIS Neurosciences (PMN) risk factors

Item 1A of every ProMIS Neurosciences Inc. 10-K on file, and what changed from one year to the next.

Open PMN in Gloomberb →
  • FY2025 10-K risk factors

    69 risks, 9 new, 9 dropped, 7 reworded since the prior year. ProMIS Neurosciences faces risks from third-party reliance for manufacturing and clinical trials of product candidates like PMN310. Nasdaq compliance issues and intellectual property enforcement dominate the risk profile. Integration of artificial intelligence introduces new operational and cybersecurity vulnerabilities.

    Filed Mar 25, 2026
  • FY2024 10-K risk factors

    69 risks. ProMIS Neurosciences faces heavy reliance on its lead Alzheimer's disease candidate PMN310, early-stage development risks, and an accumulated deficit of $90.7 million.

    Filed Mar 31, 2025